Birchbrook’s CME Group CME Stock Holding History

Birchbrook’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-49	Closed	-$10.3K	–	284
2023 Q4	$10.3K	Buy	+49	New	+$10.5K	0.01%	211

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Birchbrook's CME Position: Q1 2024 in Review

Birchbrook sold out of CME Group (CME) in Q1 2024, closing a stake of 49 shares — an estimated $10.3K sold.

Birchbrook first reported a position in CME in Q4 2023 and held it in 1 quarter. The position peaked at $10.3K in Q4 2023. 1,372 funds tracked by Wall St. Rank hold CME as of Q1 2024.

Birchbrook reported no remaining CME Group position as of Q1 2024 after selling out during the quarter.
Birchbrook sold 49 CME Group shares in Q1 2024, an estimated $10.3K.
Birchbrook first reported a position in CME Group in Q4 2023 and held it in 1 quarter.
Birchbrook's CME Group position peaked at $10.3K in Q4 2023.
1,372 funds tracked by Wall St. Rank held CME Group as of Q1 2024.

Based on Birchbrook's 13F filing for Q1 2024, filed 10 Jun 2025.